PubRank

A Single Arm 48-Week Follow-on Safety Study to a Core Study Comparing the Efficacy and Tolerability of Tobrineb®/Actitob®/Bramitob® Versus TOBI® (CT03Ext)

Clinical Trial ID NCT01111383

PubWeight™ 0.77‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01111383

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989 40.22
2 Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989 21.46
3 Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 20.55
4 Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 1991 7.12
5 Cystic fibrosis. Am Rev Respir Dis 1976 6.62
6 Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med 1999 6.23
7 Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991 5.82
8 Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992 4.30
9 Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium. J Clin Microbiol 1997 3.33
10 Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993 3.27
11 Incidence, population, and survival of cystic fibrosis in the UK, 1968-95. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 1997 2.12
12 Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci U S A 1991 2.12
13 The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr 1997 1.58
14 Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992 1.42
15 A randomised clinical trial of nebulised tobramycin or colistin in cystic fibrosis. Eur Respir J 2002 1.20
16 Incidence and mortality rates of cystic fibrosis in Japan, 1969-1992. Am J Med Genet 1995 0.97
17 Complete map of cystic fibrosis mutation DF508 frequencies in Western Europe and correlation between mutation frequencies and incidence of disease. Hum Biol 1995 0.95
18 Cystic fibrosis: How do CFTR mutations cause cystic fibrosis? Curr Biol 1995 0.89
19 Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa. Infection 1987 0.83
20 [Italian Cystic Fibrosis Registry: 10 years of activity]. Epidemiol Prev 1999 0.80
21 Long-term efficacy and safety of aerosolized tobramycin 300 mg/4 ml in cystic fibrosis. Pediatr Pulmonol 2014 0.77
22 Allergy to semisynthetic penicillins in cystic fibrosis. J Pediatr 1984 0.75
Next 100